Status:

UNKNOWN

Rationale, Design and Methods for the Early Surgery in Infective Endocarditis Study (ENDOVAL)

Lead Sponsor:

Instituto de Ciencias del Corazon

Conditions:

Infective Endocarditis

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

Background: Prognosis of infective endocarditis is poor and has remained steady over the last four decades. Several nonrandomized studies suggest that early surgery could improve prognosis. Methods: ...

Detailed Description

BACKGROUND Whereas mortality has been dramatically reduced in some areas of cardiac diseases thanks to continuous progress in treatment, endocarditis remains a high-mortality disease with steady perce...

Eligibility Criteria

Inclusion

  • Patients older than 18 years.
  • Infective endocarditis diagnosed by modified Duke criteria.
  • At least one of the following risk factors:
  • Periannular complications
  • New onset auriculo-ventricular block
  • New onset severe valvular insufficiency
  • Early-onset prosthetic valve endocarditis
  • Staphylococcus aureus endocarditis
  • Vegetations greater than 20 mm

Exclusion

  • Patients with urgent/emergent indication of surgery when endocarditis is diagnosed:
  • Heart failure because of valvular insufficiency.
  • Fungal endocarditis.
  • Septic shock.
  • Patients referred from other centers to be operated on.
  • Patients without echocardiographic evidence of endocarditis.
  • Pregnant or lactating women.
  • Simultaneous participation in other research study.
  • Incapacity to mantein the conditions of the study.
  • Patients referred from other centers more than 5 days after the diagnosis of infective endocarditis.
  • Patients with prohibitive risk for surgery due to comorbidities, estimated by previous validated scales. An Euroescore value greater than 40% will be considered a contraindication to enter the protocol.
  • Patients with ischemic or haemorragic stroke within one month before the diagnosis of endocarditis.
  • Endocarditis in intravenous drug addicts patients.
  • Not signed the inform consent.

Key Trial Info

Start Date :

September 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2010

Estimated Enrollment :

216 Patients enrolled

Trial Details

Trial ID

NCT00624091

Start Date

September 1 2007

End Date

September 1 2010

Last Update

February 26 2008

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Universitary Hospital of Valladolid

Valladolid, Spain, 47003